Exagen Inc (XGN) Stock Price, Quote, News & History

XGNNASDAQ
$2.99
-0.09-2.92%
At close: Apr 17, 5:00 PM EST
$2.99
-0.09-2.92%
Pre-Market: 4:09 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-13.63M
Investing Cash Flow (TTM)
-626.00K
Financing Cash Flow (TTM)
24.44M
Free Cash Flow (TTM)
-14.27M
Capital Expenditure (TTM)
-641.00K
Net Change in Cash (TTM)
10.18M

Analyst Trends and Forecast

1
Jan
2
Feb
4
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$65.40M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.97
PB Ratio (TTM)
4.12
Earnings Yield % (TTM)
-31.10%
Earnings Yield % (FWD)
-24.08%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.73

Company Debt

Total Debt
$22.91M
LT Debt
$22.26M
LT Debt Issuance (TTM)
$23.67M
LT Debt Repayment (TTM)
-$20.79M
Total Cash
$32.22M
Debt to Equity
1.47
Issuance of Debt (TTM)
$2.88M
Repayment of Debt (TTM)
-$20.79M

Key Statistics

Open
-
Close
$2.99
Volume / Avg.
0 / 371.38K
Day Range
- - -
52 Wk Range
2.59 - 12.23
Market Cap
$71.92M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
7.67%
Days to Cover
5.88

About

Sector
Health Care
Industry
Biotechnology
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Exagen (XGN) stock?

A

You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Exagen (XGN) stock?

A

Exagen has a consensus price target of $8.86.

Q

What is the current price for Exagen (XGN)?

A

The stock price for Exagen (NASDAQ: XGN) is $2.99 last updated April 20, 2026 at 4:00 PM EDT.

Q

Does Exagen (XGN) pay a dividend?

A

There are no upcoming dividends for Exagen.

Q

When is Exagen (NASDAQ:XGN) reporting earnings?

A

Exagen does not have any upcoming earnings scheduled.

Q

Is Exagen (XGN) going to split?

A

There is no upcoming split for Exagen.

Q

What sector and industry does Exagen (XGN) operate in?

A

Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.